Amanda Johnston

3.5k total citations · 1 hit paper
64 papers, 2.4k citations indexed

About

Amanda Johnston is a scholar working on Biotechnology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Amanda Johnston has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biotechnology, 19 papers in Oncology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Amanda Johnston's work include Cancer Research and Treatments (24 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroblastoma Research and Treatments (12 papers). Amanda Johnston is often cited by papers focused on Cancer Research and Treatments (24 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroblastoma Research and Treatments (12 papers). Amanda Johnston collaborates with scholars based in United States, United Kingdom and Australia. Amanda Johnston's co-authors include Sandra E. File, Helen A. Baldwin, Tien Chey, Alexis George, Adrian Bauman, Jacob George, Geoffrey C. Farrell, Sharon Pellow, Angelica K. Thevos and Carrie L. Randall and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Amanda Johnston

62 papers receiving 2.3k citations

Hit Papers

Sex differences in animal tests of anxiety 1991 2026 2002 2014 1991 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sex differences in animal tests of anxiety
    1991 507 citations Amanda Johnston, Sandra E. File Physiology & Behavior profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Johnston United States 25 719 516 506 473 466 64 2.4k
M. Catherine Bennett United States 26 792 1.1× 580 1.1× 254 0.5× 623 1.3× 178 0.4× 56 2.9k
Paul C. Goldsmith United States 29 767 1.1× 338 0.7× 470 0.9× 1.5k 3.1× 258 0.6× 60 3.8k
Naı̈ma Hanoun France 35 1.8k 2.5× 320 0.6× 354 0.7× 1.6k 3.4× 183 0.4× 70 4.2k
Valér Csernus Hungary 29 596 0.8× 266 0.5× 243 0.5× 633 1.3× 193 0.4× 90 2.6k
Boris Mravec Slovakia 26 351 0.5× 327 0.6× 224 0.4× 467 1.0× 55 0.1× 133 2.0k
Adriana Seilicovich Argentina 30 443 0.6× 231 0.4× 271 0.5× 638 1.3× 92 0.2× 113 2.3k
Ljubiša Vitković United States 22 449 0.6× 422 0.8× 155 0.3× 640 1.4× 110 0.2× 49 2.4k
Kevin A. Sevarino United States 24 1.7k 2.4× 164 0.3× 137 0.3× 2.2k 4.6× 317 0.7× 40 3.8k
Yahong Zhang China 23 354 0.5× 216 0.4× 225 0.4× 543 1.1× 196 0.4× 56 1.8k
Rachel C. Brown United States 23 388 0.5× 167 0.3× 193 0.4× 726 1.5× 111 0.2× 32 2.2k

Countries citing papers authored by Amanda Johnston

Since Specialization
Citations

This map shows the geographic impact of Amanda Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Johnston more than expected).

Fields of papers citing papers by Amanda Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Johnston. The network helps show where Amanda Johnston may publish in the future.

Co-authorship network of co-authors of Amanda Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Johnston. A scholar is included among the top collaborators of Amanda Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Johnston. Amanda Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, William, Laura Clifton‐Hadley, Wendi Qian, et al.. (2025). Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial. The Lancet Haematology. 12(5). e335–e345. 2 indexed citations
2.
3.
Kraehenbuehl, Lukas, Aliya Holland, Levi Mangarin, et al.. (2022). Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma. Cancers. 14(11). 2638–2638. 15 indexed citations
4.
Yao, Shuyang, Filip Jankú, Kimberly B. Koenig, et al.. (2021). Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors. Cancer Medicine. 11(2). 340–347. 21 indexed citations
5.
Szlosarek, Peter W., Akhila Wimalasingham, Melissa Phillips, et al.. (2021). Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer. Cancer Medicine. 10(19). 6642–6652. 14 indexed citations
6.
7.
Yao, Shuyang, Filip Jankú, Vivek Subbiah, et al.. (2021). Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies. British Journal of Cancer. 124(9). 1533–1539. 28 indexed citations
8.
George, Alexis, Adrian Bauman, Amanda Johnston, et al.. (2009). Independent effects of physical activity in patients with nonalcoholic fatty liver disease #. Hepatology. 50(1). 68–76. 250 indexed citations
9.
George, Alexis, Adrian Bauman, Amanda Johnston, et al.. (2008). Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. Journal of Gastroenterology and Hepatology. 24(3). 399–407. 94 indexed citations
10.
Mok, Tony, Thomas W. T. Leung, Shou‐Dong Lee, et al.. (1999). A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 44(4). 307–311. 35 indexed citations
11.
Stuart, Keith, et al.. (1999). A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma. Cancer. 86(3). 410–414. 30 indexed citations
12.
Webber, S. E., Charlotte A. Bartlett, Theodore J. Boritzki, et al.. (1996). AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. Cancer Chemotherapy and Pharmacology. 37(6). 509–517. 75 indexed citations
13.
Malcolm, Robert, et al.. (1993). Types of Benzodiazepines Abused by Chemically Dependent Inpatients. Journal of Psychoactive Drugs. 25(4). 315–319. 18 indexed citations
14.
Johnston, Amanda & Sandra E. File. (1991). Sex differences in animal tests of anxiety. Physiology & Behavior. 49(2). 245–250. 507 indexed citations breakdown →
15.
Thevos, Angelica K., Amanda Johnston, Patricia K. Latham, et al.. (1991). Symptoms of Anxiety in Inpatient Alcoholics with and without DSM‐III‐R Anxiety Diagnoses. Alcoholism Clinical and Experimental Research. 15(1). 102–105. 33 indexed citations
16.
Hale, Robert L., Amanda Johnston, & Howard C. Becker. (1990). Indomethacin does not antagonize the anxiolytic action of ethanol in the elevated plus-maze. Psychopharmacology. 101(2). 203–207. 14 indexed citations
17.
File, Sandra E. & Amanda Johnston. (1989). Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology. 99(2). 248–251. 87 indexed citations
18.
Baldwin, Helen A., Amanda Johnston, & Sandra E. File. (1989). Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. European Journal of Pharmacology. 159(2). 211–215. 71 indexed citations
19.
File, Sandra E., Amanda Johnston, & Helen A. Baldwin. (1988). Anxiolytic and anxiogenic drugs: Changes in behaviour and endocrine responses. Stress Medicine. 4(4). 221–230. 43 indexed citations
20.
Taylor, Stuart C., et al.. (1988). Kindling with the β-Carboline FG7142 Suggests Separation between Changes in Seizure Threshold and Anxiety-Related Behaviour. Neuropsychobiology. 19(4). 195–201. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Catherine Bennett Breakdown of academic impact, for papers by Paul C. Goldsmith Breakdown of academic impact, for papers by Naı̈ma Hanoun Breakdown of academic impact, for papers by Valér Csernus Breakdown of academic impact, for papers by Boris Mravec Breakdown of academic impact, for papers by Adriana Seilicovich Breakdown of academic impact, for papers by Ljubiša Vitković Breakdown of academic impact, for papers by Kevin A. Sevarino Breakdown of academic impact, for papers by Yahong Zhang Breakdown of academic impact, for papers by Rachel C. Brown
Rankless by CCL
2026